Skip to main content
. 2022 Dec;10(23):1280. doi: 10.21037/atm-22-5444

Figure 3.

Figure 3

TMED2/3/4/9 expressions correlated with clinicopathological parameters and patient prognosis in breast cancer. (A) Breast cancer transcriptomic data were analyzed to correlate TMED2/3/4/9 expression with clinical and pathological features, including age, node status, SBR score, and NPI. (B) Comparison of TMED2/3/4/9 among different molecular subtypes of breast cancer. (C) Prognostic impact of TMED2/3/4/9 in breast cancer based on the mRNA gene chip data from the KM-Plotter database. TMED, transmembrane p24 trafficking protein; SBR, Scarff-Bloom-Richardson; NPI, Nottingham Prognostic Index; mRNA, messenger RNA; KM-Plotter, Kaplan-Meier Plotter; RFS, recurrent-free survival; OS, overall survival.